InventisBio Co., Ltd
Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS9
PHASE 3 / 2-33
RECRUITING7
READOUTS ≤12 MONTHS6
| TRIAL | PHASE | STATUS | CONDITION | N | PRIMARY COMPLETION |
|---|---|---|---|---|---|
| D2570-202 NCT07035041 |
P2 | Active, not recruiting | UC - Ulcerative Colitis; Moderately to Severely Active Ulcerative Colitis | 120 | 2026-07-30 |
| D-0502 NCT06954961 |
P3 | Recruiting | Breast Cancer | 640 | 2026-11-30 |
| D-2570 Tablet NCT07326813 |
P3 | Recruiting | Plaque Psoriasis | 477 | 2027-07-12 |
| D-2570 NCT07130604 |
P3 | Recruiting | Plaque Psoriasis | 390 | 2027-07-28 |
| N/Z NCT07489885 |
P2 | Recruiting | Psoriasis | 75 | 2027-08 |
| D2570-204 NCT07315061 |
P2 | Recruiting | PsA (Psoriatic Arthritis) | 222 | 2027-08-15 |
| D2570-206 NCT07625891 |
P2 | Recruiting | Vitiligo; Non-Segmental Vitiligo (NSV) | 160 | 2027-11 |
| D-1553 NCT05379946 |
P1/2 | Active, not recruiting | Solid Tumor | 92 | 2027-12-31 (+42 mo) |
| D-2570 NCT07311200 |
P2 | Recruiting | Active Systemic Lupus Erythematosus | 120 | 2028-08-31 |